Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial  

Oleh:

Alberda, Cathy ; Gramlich, Leah ; Meddings, Jon ; Field, Catherine J. ; McCargar, Linda ; Kutsogiannis, Demetrios ; Fedorak, Richard ; Madsen, Karen

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The American Journal of Clinical Nutrition vol. 85 no. 03 (Mar. 2007), page 816.
Topik: Intestine • multiple organ dysfunction syndrome • Lactobacillus sp. • Bifidobacterium • sepsis

Ketersediaan

Perpustakaan FK Nomor Panggil: A07.K.2007.01 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

1 From the Royal Alexandra Hospital, Edmonton, Canada (CA, LG, and DK); the Department of Medicine, Division of Gastroenterology (LG, JM, RF, and KM), and the Department of Agricultural, Food, and Nutritional Science (LM), University of Alberta, Edmonton, Canada. Background: Multiple organ dysfunction syndrome (MODS) is a major cause of mortality in intensive care units. A breakdown in gut barrier function and immune dysfunction are associated with the onset of MODS. Probiotic bacteria have been shown to modulate intestinal barrier and immune function. Objective: This study assessed the efficacy of a probiotic compound in a viable and nonviable formulation in modulating intestinal permeability and immune function and preventing the onset of MODS in patients in the intensive care unit. Design: A double-blind, randomized controlled trial was conducted in the intensive care unit of a tertiary care teaching hospital. Twenty-eight critically ill patients admitted to the intensive care unit were randomly assigned to receive 1 of 3 treatments daily for 7 d: 1) placebo, 2) viable probiotics, or 3) equivalent probiotic sonicates. MODS scores and systemic concentrations of immunoglobulin (Ig) A and IgG were measured on days –1, 4, and 7, and intestinal permeability measurements were taken daily. Results: The patients responded to viable probiotics with a significantly larger increase in systemic IgA and IgG concentrations than in the patients who received placebo or sonicates (P < 0.05). MODS scores were not significantly affected by probiotic treatment. Over the study period, intestinal permeability decreased in most patients. Conclusion: Patients receiving viable probiotics show a greater enhancement in immune activity than do patients receiving either placebo or probiotic bacterial sonicates.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali